Game Changer: India Gets the World’s First Once-Weekly Insulin
Managing diabetes in India just got a whole lot easier. Novo Nordisk India has officially launched Awiqli (insulin icodec), the world’s very first once-weekly basal insulin for adults dealing with Type 1 and Type 2 diabetes.
If you or a loved one are used to the daily grind of insulin shots, you know how heavy that physical and mental burden can be. This new treatment changes the math completely, slashing the number of necessary injections from 365 daily shots to just 52 weekly doses a year.
Why This Matters: Better Control, Fewer Pricks
This is not just a minor tweak to existing treatments; it is a complete rethink of how insulin fits into daily life.
Data from global clinical trials shows that Awiqli actually outperforms the traditional once-daily glargine U100. Patients using the weekly insulin saw a superior reduction in their HbA1c levels and spent more “Time in Range,” meaning their blood sugar stayed stable throughout the day. Even better, more Type 2 diabetes patients hit their target HbA1c level of below 7% without experiencing dangerous drops in blood sugar (hypoglycemia).
Breaking Down the Barriers to Care
For years, the medical community has wanted a weekly option. In India, people who need insulin often delay starting it by an average of seven to nine years. It is easy to understand why. The fear of needles, the pain, complex dosing schedules, and worries about low blood sugar make daily injections a tough pill to swallow. Doctors also struggle with getting patients to stick to daily routines.
Medical experts point out that because daily regimens are so demanding, people often hold off on treatment until their diabetes worsens. A simplified weekly dose, delivered via a user-friendly device, could encourage patients to start treatment much earlier and take the anxiety out of the process.
Confronting India’s Health Crisis
The timing of this launch is critical. India is facing a massive diabetes epidemic, with over 101 million people living with the condition and another 136 million classified as prediabetic.
Recent data from the National Family Health Survey highlights a sharp spike in blood sugar levels across both cities and rural areas:
-
Men (15+): 20.9% now have high blood sugar or take medication, up from 15.6% a few years ago.
-
Women (15+): The numbers climbed to 17.8%, up from 13.5%.
As Type 2 diabetes progresses, the body naturally needs extra help from insulin. By cutting down the injection routine by 85%, this new weekly option aims to turn a stressful daily chore into a manageable weekly habit, giving millions of people their quality of life back.
